Welcome to our dedicated page for CERN news (Ticker: CERN), a resource for investors and traders seeking the latest updates and insights on CERN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CERN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CERN's position in the market.
Cerner Corporation (NASDAQ: CERN) will host its annual Cerner Health Conference (CHC) virtually on Oct. 12-13. Newly appointed president and CEO, Dr. David Feinberg, will deliver the keynote focused on enhancing patient experience and access to care. The conference will feature over 100 educational sessions discussing key topics like interoperability, pandemic-driven changes, and patient engagement. Attendees can earn continuing education credits and network with healthcare professionals. The theme for CHC is “One Patient. One Community. One World.”
Cerner Corporation (NASDAQ: CERN) has announced the launch of Cerner RevElate, an advanced patient accounting product aimed at enhancing its revenue cycle management portfolio. The new solution is designed to simplify and automate revenue cycle processes, integrating data across various health systems amidst ongoing industry consolidation. Key clients, including BayCare Health System, are set to implement the product in 2022. This initiative follows significant investments in clinical and financial technology, reflecting Cerner's commitment to improving profitability for healthcare providers through enhanced usability and interoperability.
Quantum Health announces Zane Burke as the new CEO, succeeding founder Kara Trott, who remains as Chairman. Burke, previously CEO of Livongo Health, brings proven experience in scaling SaaS and enterprise software healthcare companies. Under his leadership, Livongo underwent a significant IPO and merged with Teladoc for $18.5 billion, creating a virtual care giant. Quantum Health is recognized for its effective healthcare navigation model, aiming to enhance member value and expand into new markets. The company, founded in 1999, has received multiple awards for its innovative consumer-first approach.
Cerner Corporation (Nasdaq: CERN) has announced a cash dividend of $0.22 per share, payable on October 12, 2021, for shareholders of record by the close of business on September 27, 2021. Cerner aims to provide regular quarterly dividends, with future dividends contingent on the Board's evaluation of the company's financial health and operational results. The company focuses on connecting healthcare systems to enhance patient care and operational efficiency.
Cerner Corporation (Nasdaq: CERN) appointed Dr. David Feinberg as President and CEO, effective October 1, 2021, following Brent Shafer's transition from the roles of Chairman and CEO. William Zollars has been named independent Chairman. Dr. Feinberg previously led Google Health and has extensive experience in healthcare leadership, including at Geisinger Health. The Board believes his expertise will drive Cerner's growth and healthcare transformation. The transition aims to position Cerner for success in a competitive market.
Cerner (NASDAQ: CERN) has launched a new solution called Cerner Determinants of Health aimed at tackling healthcare disparities by addressing social determinants of health. This dashboard, integrated into its electronic health record system, helps clinicians identify social risk factors affecting patient health. With studies indicating that non-clinical factors can influence up to 80% of health outcomes, Cerner's initiative is essential for improving health equity. The solution enables targeted outreach and collaboration with organizations like Northern Light Health to better address social needs.
Cerner Corporation (Nasdaq: CERN) reported its second-quarter results for 2021, with gains in adjusted operating margin and diluted EPS compared to the previous year. However, GAAP operating margin and diluted EPS saw declines due to restructuring charges. The company's earnings conference call took place on July 30, 2021, allowing investors to delve into the results and future outlook. Despite challenges, the company continues to expand its operational efficiency and financial metrics.
Cerner Corporation (Nasdaq: CERN) will release its Q2 2021 earnings results before the market opens on July 30, 2021. Following the release, a conference call is scheduled for 8 a.m. CT to discuss performance, provide an outlook, and answer investor questions. Participants can join via dial-in at (678) 509-7542 or through a live audio webcast available on Cerner’s website. Cerner focuses on health technologies and offers integrated clinical and financial systems for healthcare providers worldwide.
Cerner Corporation (NASDAQ: CERN) is expanding its partnership with Baystate Health to introduce a digital health platform aimed at improving patient care in Western Massachusetts. This platform will enhance access to personalized care and support clinicians with data for effective disease management. The initiative includes deploying Cerner's HealtheIntent® for streamlined primary care and revenue cycle management solutions, thus transforming patient access and billing experience. The collaboration signifies a commitment to innovative, value-based care.
FAQ
What is the market cap of CERN (CERN)?
